CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Tanay Loya
/ Categories: Trending, Markets

DB Corp ascends post share buyback approval

Shares of Media firm DB Corp gained over 7 per cent on Monday after the company’s shareholders approved Rs. 312 .8 crore share buyback proposal.

The company will buyback up to 92 lakh fully paid-up equity shares of face value Rs. 10 each at a price of Rs. 340 per equity share.

Last month, the company had said that the buyback would be subject to approval of the shareholders by way of a special resolution through postal ballot and all other applicable statutory approvals. The company in a BSE filing on Saturday said that the special resolution was passed with requisite majority.

D.B. Corp is a print media company engaged in the sale of newspapers and magazines. It also has presence in radio and digital sectors.

At 11:43 hours on Monday, DB corp was trading at Rs. 277.25 per share, up Rs. 16.10 or 6.17 per cent on BSE. The scrip opened at Rs. 270 and touched an intraday high of Rs. 280.5 per share on BSE. The stock attracted traded volume of 35,756 shares on BSE.


Previous Article Cadila Healthcare gains on tentative approval for Deferasirox tablets
Next Article NCLT rules in favour of Tata Sons; Tata group stocks up
Print
1945 Rate this article:
3.5
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR